Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Core outcomes for studies of pregnancy with epilepsy.

Mawer G.

BJOG. 2016 Nov 22. doi: 10.1111/1471-0528.14432. [Epub ahead of print] No abstract available.

PMID:
27878948
2.

Fine-tuning risk assessment with antiepileptic drug use in pregnancy.

Mawer G, Bromley R, Baker GA, Meador KJ, Clayton-Smith J.

Neurology. 2015 Oct 13;85(15):1354. doi: 10.1212/WNL.0000000000002050. No abstract available.

PMID:
26459942
3.

IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.

Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J; Liverpool and Manchester Neurodevelopment Group..

Neurology. 2015 Jan 27;84(4):382-90. doi: 10.1212/WNL.0000000000001182.

4.

The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.

Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, García-Fiñana M, Kneen R, Lucas SB, Shallcross R, Baker GA; Liverpool and Manchester Neurodevelopment Group..

J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270.

5.

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group..

Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X.

6.

Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group..

Neurology. 2012 Apr 17;78(16):1207-14. doi: 10.1212/WNL.0b013e318250d824. Erratum in: Neurology. 2012 May 15;78(20):1622.

7.

Child development following in utero exposure: levetiracetam vs sodium valproate.

Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA; Liverpool Manchester Neurodevelopment Group.; UK Epilepsy and Pregnancy Register..

Neurology. 2011 Jan 25;76(4):383-9. doi: 10.1212/WNL.0b013e3182088297.

8.

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group..

Brain. 2011 Feb;134(Pt 2):396-404. doi: 10.1093/brain/awq352.

9.

Effects of breastfeeding in children of women taking antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group..

Neurology. 2010 Nov 30;75(22):1954-60. doi: 10.1212/WNL.0b013e3181ffe4a9.

10.

Early cognitive development in children born to women with epilepsy: a prospective report.

Bromley RL, Mawer G, Love J, Kelly J, Purdy L, McEwan L, Briggs M, Clayton-Smith J, Shi X, Baker GA; Liverpool and Manchester Neurodevelopment Group [LMNDG]..

Epilepsia. 2010 Oct;51(10):2058-65. doi: 10.1111/j.1528-1167.2010.02668.x. Erratum in: Epilepsia. 2012 Aug;53(8):1470. Sin, Xin [corrected to Shi, Xin].

11.

Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study.

Mawer G, Briggs M, Baker GA, Bromley R, Coyle H, Eatock J, Kerr L, Kini U, Kuzmyshcheva L, Lucas SB, Wyatt L, Clayton-Smith J; Liverpool & Manchester Neurodevelopment Group..

Seizure. 2010 Mar;19(2):112-9. doi: 10.1016/j.seizure.2009.11.008.

12.

Antiepileptic drug use in women of childbearing age.

Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, Liporace JD, Sam M, Kalayjian LA, Thurman DJ, Moore E, Loring DW; NEAD Study Group..

Epilepsy Behav. 2009 Jul;15(3):339-43. doi: 10.1016/j.yebeh.2009.04.026.

13.

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group..

N Engl J Med. 2009 Apr 16;360(16):1597-605. doi: 10.1056/NEJMoa0803531.

14.

Autism spectrum disorders following in utero exposure to antiepileptic drugs.

Bromley RL, Mawer G, Clayton-Smith J, Baker GA; Liverpool and Manchester Neurodevelopment Group..

Neurology. 2008 Dec 2;71(23):1923-4. doi: 10.1212/01.wnl.0000339399.64213.1a. No abstract available.

PMID:
19047565
15.

The behavioral consequences of exposure to antiepileptic drugs in utero.

Vinten J, Bromley RL, Taylor J, Adab N, Kini U, Baker GA; Liverpool and Manchester Neurodevelopment Group..

Epilepsy Behav. 2009 Jan;14(1):197-201. doi: 10.1016/j.yebeh.2008.10.011.

PMID:
18992367
16.

In utero antiepileptic drug exposure: fetal death and malformations.

Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC; NEAD Study Group..

Neurology. 2006 Aug 8;67(3):407-12.

17.

The longer term outcome of children born to mothers with epilepsy.

Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW.

J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1575-83.

18.
19.
20.
Items per page

Supplemental Content

Loading ...
Support Center